Pharma IT ApS: Financial statements 2017
CVR: 37320595
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Pharma IT ApS (CVR 37320595) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 12,508,992 and a net result of DKK 735,135 compared with DKK 853,845 the year before. That is an increase of 150.2% compared with the year before. Equity in the 2017 report amounted to DKK 1,688,980. The solvency ratio was 19.2%.
- Gross Profit
- DKK 12,508,992
- Profit/Loss
- DKK 735,135
- Equity
- DKK 1,688,980
- Total Assets
- DKK 8,774,103
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 12.5 mio. | 735 t. | 1.7 mio. | - |
| 2016 | - | 5 mio. | 854 t. | 954 t. | - |
Keep an eye on Pharma IT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 9, 2017, 18. juni 2024 P/S has been appointed auditor of Pharma IT ApS.
As of October 9, 2017, Jakob Juul Rasmussen is registered as adm. dir. of Pharma IT ApS.
As of October 9, 2017, Søren Winkel is registered as director of Pharma IT ApS.
As of August 31, 2017, Jakob Juul Rasmussen has stepped down as adm. dir. of Pharma IT ApS.
As of August 31, 2017, Heidi Billeschou Noer Troelsen has stepped down as director of Pharma IT ApS.
As of August 31, 2017, Søren Winkel has stepped down as director of Pharma IT ApS.
About Pharma IT ApS
Pharma IT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Jakob Juul Rasmussen, Søren Winkel and Peter-Emil Iversen. The company is owned by ProductLife ApS. The company has 31 employees (2018). In 2025, the company reported a gross profit of DKK 137,832,741 and a net result of DKK -1,068,285 compared with DKK 21,437,534 the year before. Equity in the 2025 report amounted to DKK 47,568,805.